Drug information for PEGANONE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
250MG
Prescription
(Reference Drug)
ETHOTOIN
ethotoin
LUNDBECK INC
10841
2011-06-02 Letter
2010-06-30 Other
2010-06-24 Medication Guide
2010-06-14 Label
2010-06-14 Letter
2009-04-29 Letter
2009-04-28 Label
2007-02-21 Label
2007-02-12 Letter
2003-10-01 Letter
2003-10-01 Letter
TABLET; ORAL
500MG
Discontinued
ETHOTOIN
ethotoin
LUNDBECK INC
"
Drug Adverse Effects information for PEGANONE
Role code
Indications
Reaction
# Reports
PS
EPILEPSY
DIPLOPIA
1
PS
EPILEPSY
OSTEOPOROSIS
1
C
OSTEOPOROSIS
BACK DISORDER
3
C
OSTEOPOROSIS
BACK PAIN
3
C
OSTEOPOROSIS
BALANCE DISORDER
3
C
OSTEOPOROSIS
DEVICE BREAKAGE
3
C
OSTEOPOROSIS
DISTURBANCE IN ATTENTION
3
C
OSTEOPOROSIS
FALL
3
C
OSTEOPOROSIS
HEAD INJURY
3
C
OSTEOPOROSIS
HOSPITALISATION
1
C
OSTEOPOROSIS
INJECTION SITE PAIN
3
C
OSTEOPOROSIS
JOINT DISLOCATION
3
C
OSTEOPOROSIS
LIMB DISCOMFORT
3
C
OSTEOPOROSIS
LIMB INJURY
3
C
OSTEOPOROSIS
LUMBAR HERNIA
3
C
OSTEOPOROSIS
MOBILITY DECREASED
3
C
OSTEOPOROSIS
MUSCLE SPASMS
3
C
OSTEOPOROSIS
NECK PAIN
3
C
OSTEOPOROSIS
NERVE COMPRESSION
3
C
OSTEOPOROSIS
NERVOUS SYSTEM DISORDER
3
C
OSTEOPOROSIS
PAIN IN EXTREMITY
3
C
OSTEOPOROSIS
SENSORY LOSS
3
C
OSTEOPOROSIS
SPINAL COLUMN INJURY
3
C
OSTEOPOROSIS
WEIGHT INCREASED
3
Ads by Google